Скачать с ютуб Engineering patient-derived tumoroids to enable high-throughput screening for immuno-oncology... в хорошем качестве

Engineering patient-derived tumoroids to enable high-throughput screening for immuno-oncology...

Presented By: Garrett Wong, MS Speaker Biography: Garrett Wong received his MS in 2017 from University of California, San Diego modeling the role of skeletal muscle in spinal bulbar muscular atrophy using iPSCs. Starting off as a junior scientist in 2018, now, he is a manager for the cell biology services team at Thermo Fisher Scientific... Webinar: Engineering patient-derived tumoroids to enable high-throughput screening for immuno-oncology... Webinar Abstract: Patient-derived tumoroids, commonly referred to as cancer organoids, represent a promising avenue as cost-effective and biologically relevant cancer immunotherapy research models. In this study, we developed a proof-of-concept immunotherapy screening platform harnessing tumoroids to validate the cytotoxic activity of Natural Killer (NK) cells... Labroots on Social: Facebook:   / labrootsinc   Twitter:   / labroots   LinkedIn:   / labroots   Instagram:   / labrootsinc   Pinterest:   / labroots   SnapChat: labroots_inc